Literature DB >> 7732439

Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD).

J B Young1, D H Weiner, S Yusuf, C M Pratt, J B Kostis, M B Weiss, E Schroeder, M Guillote.   

Abstract

To determine patterns of medication use based on clinical variables in patients with heart failure, we analyzed data from 5,999 patients participating in the Registry of Studies of Left Ventricular Dysfunction (SOLVD). The Registry comprised a broad spectrum of patients with heart failure, including some with predominantly diastolic dysfunction. Drug use was determined in a population cross-sectional manner at the time of identification (74% hospitalized). The median number of drugs per patient was four, with diuretics taken by 62%, digitalis by 45%, angiotensin-converting enzyme inhibitors (ACE-I) by 32%, calcium channel blockers by 36%, antiarrhythmics by 22%, and beta-blockers by 18%. Only 18% were on the combination of ACE-I, diuretic, and digitalis. Stratification for diagnosis, heart failure symptoms, and ejection fractions demonstrated that triple-drug therapy (digitalis, diuretic, and ACE-I) was common only in those with ejection fractions less than .20 and several signs or symptoms of heart failure. Older patients were taking diuretics frequently (73% of patients older than 70 years of age), and our European center used fewer drugs overall, while prescribing digitalis about half as frequently as North American clinics. These data serve as the baseline for analysis of evolving therapeutic practice in patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732439     DOI: 10.1097/00007611-199505000-00002

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?

Authors:  M A Scheiner; S E Kimmel
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

Review 2.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

3.  Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.

Authors:  M H Chin; P D Friedmann; C K Cassel; R M Lang
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

Review 4.  Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.

Authors:  F Andersson; C Cline; T Rydén-Bergsten; L Erhardt
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

5.  Factors contributing to the hospitalization of patients with congestive heart failure.

Authors:  M H Chin; L Goldman
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

6.  Quality of congestive heart failure treatment at a Canadian teaching hospital.

Authors:  E Weil; J V Tu
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

7.  Prescription patterns of diuretics in Dutch community-dwelling elderly patients.

Authors:  D J van Kraaij; R W Jansen; J J de Gier; F W Gribnau; W H Hoefnagels
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.